Enjoy 20% off all recombinant proteins from MedChemExpress and benefit from special pricing on selected additional products. Additionally, save 13% on Ready-to-Use Compound Libraries. Discounts are already reflected in the displayed prices and cannot be combined. Hurry, offer ends May 31, 2026.
Product Description: Dxd-d5 is a deuterium labeled Dxd. Dxd is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a) [1].
Applications: Cancer-programmed cell death
Formula: C26H19D5FN3O6
References: [1]Ogitani Y, et al. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clin Cancer Res. 2016 Oct 15;22(20):5097-5108./[2]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
Molecular Weight: 498.51
Compound Purity: 98.89
Research Area: Cancer
Solubility: DMSO : ≥ 40mg/mL
Target: ADC Payload;Topoisomerase
English
Deutsch
